Optima Pharma

Optima Pharma, headquartered in Germany and operating in the Chemical and fertilizer minerals, salt and other mining and quarrying products n.e.c. industry, has reported its carbon emissions and climate commitments.

In 2020, Optima Pharma's total reported emissions were 372,000 kg CO2e. This included Scope 1 emissions of 11,160 kg CO2e, Scope 2 emissions of 11,160 kg CO2e, and Scope 3 emissions of 349,680 kg CO2e. The company also reported emissions in 2014, with a total of 383,000 kg CO2e, comprising 22,980 kg CO2e from Scope 1, 15,320 kg CO2e from Scope 2, and 344,700 kg CO2e from Scope 3. No specific emissions data is available for 2021.

Optima Pharma has set climate commitments, including a target to reduce its Scope 1 and 2 carbon footprint from its own operations by at least 50% by 2030 (versus 2021 levels) and aims to achieve net-zero emissions by 2050 for Scope 1 and Scope 2. The company also states a commitment to continue compensating 100% of non-avoidable Scope 1 and Scope 2 emissions over the coming years, spanning from 2023 to 2050. Furthermore, Optima Pharma plans to reduce its operational carbon footprint by an additional 25% by 2030 through measures such as increasing energy and resource efficiency and expanding sustainable mobility. This is building on an existing 40% reduction achieved since 2009 by sourcing green electricity and implementing other measures.